| Name | Gene(s) | Key Features | Diagnosis | Treatment Notes |
|---|---|---|---|---|
| Glucose-Galactose Malabsorption (GGM) | SGLT1 | Neonatal diarrhea, metabolic acidosis, glycosuria | ↓ stool pH, ↑ osmolarity, abnormal glucose /galactose breath H₂ test | Glucose/lactose-free diet; fructose-based formula
(Ross-carb free) |
| Sucrase-Isomaltase Deficiency (SI) | SI | Symptoms with sucrose/dextrins; tolerates glucose;
greenland founder variant |
↓ stool pH, variable reducing substances -since sucrose is a nonreducing sugar, abnormal sucrose breath H₂ test | Sucrose-free diet; sacrosidase supplements |
| Congenital Lactase Deficiency | LCT | Diarrhea with lactose; Finnish founder variant | ↓ lactase, normal sucrase; abnormal lactose breath H₂ test | Lactose-free diet; lactase enzyme supplements |
| Congenital Chloride Diarrhea | SLC26A3 | Secretory diarrhea, polyhydramnios,
metabolic alkalosis Most common cause of congenital secretory diarrhea |
↑ stool Cl⁻ (>90 mmol/L) | Oral NaCl/KCl; butyrate; PPIs |
| Congenital Sodium Diarrhea | SLC9A3 | Na⁺-secreting diarrhea, polyhydramnios | Clinical features; no syndromic signs | Supportive care |
| Syndromic Na⁺ Diarrhea (SPINT2) | SPINT2 | Mixed diarrhea, tufted cells, keratitis, choanal atresia,
bone malformations |
Villous atrophy, crypt hyperplasia, normal EpCAM staining indistinguishable from CTE |
Nutritional support; symptom management |
| Enterokinase Deficiency | PRSS7 | Protein malabsorption, edema, hypoproteinemia | Normal histology; low pancreatic enzymes. Diarrhea improves with elemental diet | PERT for first 2 years; symptoms resolve after 2yrs. |
| DGAT1 Deficiency | DGAT1 | Osmotic diarrhea, PLE, hypertriglyceridemia | Villous atrophy; ↑ triglycerides | Low-fat diet; no TPN required |
| Name | Gene(s) | Key Features | Diagnosis | Treatment Notes |
|---|---|---|---|---|
| Microvillus Inclusion Disease (MVID) | MYO5B, STX3 | Secretory + osmotic diarrhea, liver disease, TPN dependence | Villous atrophy, crypt hypoplasia, EM: microvillus loss, inclusion bodies (CD10/PAS+) | TPN; possible weaning in late-onset cases |
| Congenital Tufting Enteropathy (CTE) | EpCAM | Mixed diarrhea, tufted cells, crypt hyperplasia | Negative EpCAM staining; villous atrophy | TPN; supportive care |
| Trichohepatoenteric Syndrome | TTC37, SKIV2L | Diarrhea, woolly hair, dysmorphism, hepatomegaly, immune defects | Villous atrophy, inflammatory infiltrate | Nutritional support; immune therapy |
| Netherton Syndrome | SPINK5 | Diarrhea, ichthyosis, bamboo hair, ↑ IgE, eosinophilia | Villous atrophy | Allergy management; supportive care |
| Kabuki Syndrome 1 | MLL2 AD |
Malabsorptive diarrhea, dysmorphism, seizures, GI
anomalies (malro, imperforate, stenosis, fistula) |
Clinical features; genetic testing | Multidisciplinary care |
| Enteric Anendocrinosis | NEUROG3 | Osmotic diarrhea, absent EE cells by antichromogranin stain, diabetes risk | Normal architecture; absent chromogranin A staining | Diarrhea persists indefinitely...but may wean off TPN after age 2–3 |
| Enteric Dysendocrinosis | PCSK1 | Osmotic diarrhea, ↑ proinsulin, multiple endocrinopathies | Normal EE cells; hormonal assays | Hormone replacement; supportive care |
| Mitchel-Riley Syndrome | RFX6 | Diarrhea, neonatal diabetes, GI and biliary anomalies | Clinical features; genetic testing | Endocrine and nutritional support |
| IPEX Syndrome | FOXP3 x-linked |
Severe diarrhea, dermatitis, neonatal diabetes, autoimmunity | Villous atrophy, mononuclear infiltrate, ↑ IgE, ↓ Tregs | Immunosuppression; bone marrow transplant |
| Neonatal Inflammatory Skin/Bowel Disease | ADAM17 | Diarrhea (± bloody), rash, hepatitis, recurrent sepsis | Villus blunting, crypt hyperplasia, neutrophilic skin infiltrates | Immune therapy; supportive care |
| IL-10 or IL-10R Deficiency | IL10, IL10R | Early-onset enterocolitis, fistulas, folliculitis, arthritis | STAT3 phosphorylation assay; genetic sequencing | Hematopoietic stem cell transplant |
| CD25/IL2RA Deficiency | IL2RA | IPEX-like diarrhea, infections (CMV), eczema, lymphoid hypertrophy | Severe villous atrophy; immune profiling | Immunosuppression; antibiotics |
| STAT1 Deficiency | STAT1 AD |
Diarrhea, candidiasis, autoimmune disease, vascular anomalies | Villous atrophy, lymphocytic/eosinophilic infiltrates; genetic testing | Targeted immune therapy; supportive care |